SnoreLessNow Co-Founder on the Anti-Snore Mouth Guard+
SnoreLessNow co-founder Chris Garvey spoke with Orthodontic Products about the Anti-Snore Mouth Guard+ and the importance of sleep treatment.
SnoreLessNow co-founder Chris Garvey spoke with Orthodontic Products about the Anti-Snore Mouth Guard+ and the importance of sleep treatment.
Under this new agreement, Vivos becomes the exclusive U.S. and Canadian distributor of the FDA-approved NR6 Rhinomanometer, a specialized diagnostic device for evaluating nasal breathing and function in dental patients with sleep and breathing issues.
Michele Reeder has been appointed as the senior vice president of affiliate services at the ADA, focused on organizational relations.
The book addresses the connection between dentofacial anomalies and developmental deficiencies closely associated with downstream conditions such as OSA.
Read MoreThe service will be offered via telemedicine for all Vivos-trained dental professionals to use as a therapeutic protocol in tandem with the Vivos System.
Read MoreThe mmRNA oral appliance is the new version of the companies existing mRNA appliance which is indicated to treat mild-to-moderate OSA, sleep disordered treating, and snoring in adults.
Read MoreThis agreement will allow dental practitioners to use the precise scans in a validated workflow as a basis to create a custom-made Digital Sleep Apnea Device (D-SAD).
Read MoreTeledontics transforms conventional restrictive orthodontic approaches, that are harmful to the upper airway, into more precise and preventive ones.
Read MoreA close-up look at some of the products currently on the market to help treat your patients
Read MoreThe Sleep Education Consortium’s 15th Annual Sleep Conference will focus on the growing link between dentistry and sleep medicine and how dental professionals can play a larger role.
Read MoreThe Oasys Hinge Appliance is designed to gently shift the lower jaw forward during sleep to activate the airway muscles and ligaments to prevent airway collapse.
Read MoreThe partnership is aimed at broadening Vivos Therapeutics reach in the dental market with its noninvasive, non-surgical, non-pharmaceutical, multidisciplinary treatment modality for mild to moderate OSA.
Read More